3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
13
Urinary Bladder Neoplasms
12
Neoplasms
10
Carcinoma, Renal Cell
9
Ovarian Neoplasms
7
Carcinoma, Transitional Cell
7
Neoplasm Metastasis
6
Pancreatic Neoplasms
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Merkel Cell
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Lymphoma
3
Lung Neoplasms
3
Fallopian Tube Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Kidney Neoplasms
2
Kidney Diseases
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Urothelial Cancer
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Turcot syndrome
1
Interventions
Ipilimumab
6
pembrolizumab
5
Nivolumab
5
Dacarbazine
5
CTLA-4 Antigen
4
Carboplatin
3
Bevacizumab
3
relatlimab
2
aflibercept
2
Temozolomide
2
Ranibizumab
2
Radiosurgery
2
Paclitaxel
2
Lenalidomide
2
Immunoglobulin G
2
Embolization, Therapeutic
2
Disulfides
2
Cyclophosphamide
2
Colony-Stimulating Factors
2
Albumin-Bound Paclitaxel
2
AZD 6244
2
130-nm albumin-bound paclitaxel
2
utomilumab
1
ulixertinib
1
trametinib
1
tebentafusp
1
sotrastaurin
1
sargramostim
1
poly ICLC
1
pasireotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uveal Melanoma
×
avelumab
×
Clear all
No trials found.